Medicure Inc V.MPH

Alternate Symbol(s): MCUJF

Healthcare Biotechnology

Medicure Inc. is a pharmaceutical company. It is focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market. The focus of it is the marketing and distribution of AGGRASTAT (tirofiban hydrochloride) injection and ZYPITAMAG (pitavastatin) tablets in the United States, where they are sold through the Company's United States subsidiary, Medicure Pharma Inc. It also operates Marley Drug Inc. (Marley Drug), a pharmacy subsidiary servicing all 50 states, Washington D.C. and Puerto Rico. Marley Drug is committed to improving access to medication for all Americans together with exceptional customer service and free home delivery. AGGRASTAT is indicated to reduce the rate of thrombotic cardiovascular events in patients with non-ST elevation acute coronary syndrome. It also develops pyridoxal 5'-phosphate analogues (P5P Analogues), the processes for their preparation, compositions containing P5P Analogues.

TSXV:MPH - Post by User

Medicure Inc

Bullboard Posts

Comment by zwerp2000on Aug 12, 2015 10:51am

143 Views

Post# 24010625

RE:RE:Is Apicore bringing in any money?

I was the one at the end of the conference call that asked about Apicore. I specifically asked if there was a set price to buy the remaining percentage of the company or did it fluctuate based on the growth of Apicore. The company said it was a set price. I should've asked what that price was but nonetheless, if apicore is doing so well then hopefully they can buy more of an ownership at a price that would be considered a bargain

Bullboard Posts

Canada Nickel unveils second of seven resources planned by mid-2025